WAGGONER KENNETH L. enters PHARMACYTE BIOTECH, INC. with 20.60K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.60K | Direct |
| Total | 20.60K | 20.60K direct |
Stock Option (right to buy)
DirectUnderlying shares
3K
Shares owned
N/A
Exercise price
61.20
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
3K
Shares owned
N/A
Exercise price
83.70
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
3K
Shares owned
N/A
Exercise price
74.25
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
3K
Shares owned
N/A
Exercise price
156.00
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
3K
Shares owned
N/A
Exercise price
10.05
Expiration
—
Exercise window
—
Underlying
15K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 61.20 | — | — | 3K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 83.70 | — | — | 3K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 74.25 | — | — | 3K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 156.00 | — | — | 3K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 10.05 | — | — | 3K | N/A |
| Total | 15K | 0.00 | ||||